secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARYA Sciences Acquisition Corp IV (—)
CIK:        0001838821
Form:       8-K
Filed at:   2024-03-29T23:59:59+00:00
Accession:  0001140361-24-016371
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq adds annual meeting deficiency as separate delisting basis for ARYA; hearing April 25
--------------------------------------------------------------------------------

- Additional Nasdaq delisting notice for failure to hold annual meeting within 12 months of FYE (Rule 5620(a)).
- Hearing before Nasdaq Panel scheduled April 25, 2024 to consider both delisting bases.
- Trading previously stayed; no assurance of continued listing on Nasdaq Capital Market.
- Proposed business combination with Adagio Medical at risk if delisting occurs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1838821/000114036124016371/0001140361-24-016371-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1838821/000114036124016371/ef20025513_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-016371

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer